Synlett 2021; 32(09): 935-939
DOI: 10.1055/a-1373-7017
letter

Silyl Cyanopalladate-Catalyzed Friedel–Crafts-Type Cyclization Affording 3-Aryloxindole Derivatives

Hamdiye Ece
a  Graduate School of Chemical Sciences and Engineering, Hokkaido University, Kita 8, Nishi 5, Sapporo, Hokkaido 060-0808, Japan
,
Yuji Tange
a  Graduate School of Chemical Sciences and Engineering, Hokkaido University, Kita 8, Nishi 5, Sapporo, Hokkaido 060-0808, Japan
,
b  Division of Applied Chemistry and Frontier Chemistry Center, Faculty of Engineering, Hokkaido University, Kita 13, Nishi 8, Sapporo, Hokkaido 060-8628, Japan
,
b  Division of Applied Chemistry and Frontier Chemistry Center, Faculty of Engineering, Hokkaido University, Kita 13, Nishi 8, Sapporo, Hokkaido 060-8628, Japan
› Author Affiliations
This work was supported by Grants-in-Aid from the Japan Society for the Promotion of Sciences (JSPS) (Nos. 19H02706 and 19K15548). T.Y. also acknowledges support from the Feasibility Study Program of the Frontier Chemistry Center, Faculty of Engineering, Hokkaido University.


Abstract

3-Aryloxindole derivatives were synthesized through a Friedel–Crafts-type cyclization. The reaction was catalyzed by a trimethylsilyl tricyanopalladate complex generated in situ from trimethylsilyl cyanide and Pd(OAc)2. Wide varieties of diethyl phosphates derived from N-arylmandelamides were converted almost quantitatively into oxindoles. When N,N-dibenzylamide was used instead of an anilide substrate, a benzo-fused δ-lactam was obtained. An oxindole product was subjected to substitution reactions to afford 3,3-diaryloxindoles with two different aryl groups.

Supporting Information



Publication History

Received: 24 December 2020

Accepted after revision: 26 January 2021

Publication Date:
26 January 2021 (online)

© 2021. Thieme. All rights reserved

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References and Notes

  • 1 Uddin MK, Reignier SG, Coulter T, Montalbetti C, Grånäs C, Butcher S, Krong-Jensen C, Felding J. Bioorg. Med. Chem. Lett. 2007; 17: 2854
    • 2a Hewawasam P, Gribkoff VK, Pendri Y, Dworetzky SI, Meanwell NA, Martinez E, Boissard CG, Post-Munson DJ, Trojnacki KT, Yeleswaram K, Pajor LM, Knipe J, Gao Q, Perrone R, Starrett JE. Jr. Bioorg. Med. Chem. Lett. 2002; 12: 1023
    • 2b Shibata N, Ishimaru T, Suzuki E, Kirk KL. J. Org. Chem. 2003; 68: 2494
    • 3a Nagamine J, Nagata R, Seki H, Nomura-Akimaru N, Ueki Y, Kumagai K, Taiji M, Noguchi H. J. Endocrinol. 2001; 171: 481
    • 3b Tomita D, Yamatsugu K, Kanai M, Shibasaki M. J. Am. Chem. Soc. 2009; 131: 6946
  • 4 Chowdhury S, Chafeev M, Liu S, Sun J, Raina V, Chui R, Young W, Kwan R, Fu J, Cadieux JA. Bioorg. Med. Chem. Lett. 2011; 21: 3676
    • 5a Trost BM, Brennan MK. Synthesis 2009; 3003
    • 5b Kaur M, Singh M, Chadha N, Silakari O. Eur. J. Med. Chem. 2016; 123: 858
    • 6a Shaughnessy KH, Hamann BC, Hartwig JF. J. Org. Chem. 1998; 63: 6546
    • 6b Lee S, Hartwig JF. J. Org. Chem. 2001; 66: 3402
    • 6c Ackermann L, Vicente R, Hofmann N. Org. Lett. 2009; 11: 4274
    • 7a Rey V, Pierini AB, Peñéñory AB. J. Org. Chem. 2009; 74: 1223
    • 7b Soria-Castro SM, Caminos DA, Peñéñory AB. RSC Adv. 2014; 4: 17490

      Under the photoirradiation conditions, the SRN1-reaction of o-chloroanilides affords the 3-aryloxindole derivatives, see:
    • 8a Wolfe J, Sleevi MC, Goehring RR. J. Am. Chem. Soc. 1980; 102: 3646
    • 8b Goehring RR, Sachdeva YP, Pisipati JS, Sleevi MC, Wolfe JF. J. Am. Chem. Soc. 1985; 107: 435
  • 9 Beyer A, Buendia J, Bolm C. Org. Lett. 2012; 14: 3948
  • 10 Lai P.-S, Dubland JA, Sarwar MG, Chudzinski MG, Taylor MS. Tetrahedron 2011; 67: 7586
  • 11 Yurino T, Tani R, Ohkuma T. ACS Catal. 2019; 9: 4434
  • 12 Yurino T, Tange Y, Tani R, Ohkuma T. Org. Chem. Front. 2020; 7: 1308
  • 13 Yurino T, Ece H, Ohkuma T. Asian J. Org. Chem. 2020; 9: 557
  • 14 1-Methyl-3-phenyl-1,3-dihydro-2H-indol-2-one (2a): Typical Procedure A 20 mL Schlenk flask was charged with diethyl 2-[methyl(phenyl)amino]-2-oxo-1-phenylethyl phosphate (1a: 130 mg, 0.35 mmol). Pd(OAc)2 (1.6 mg, 7.0 μmol) was added, and the flask was subjected to three evacuation–argon replacement cycles. MeNO2 (2.0 mL) was added, and the solution was stirred for 15 min at 60 °C. TMSCN (71 mg, 0.72 mmol) was then added, and the mixture was stirred at 60 °C for 10 h until the reaction was complete [TLC, hexane–EtOAc (4:1)]. The reaction was quenched with sat. aq NaHCO3, and the aqueous layer was extracted with EtOAc (3 × 10 mL). The collected organic layers were washed with brine, dried (Na2SO4), filtered, and concentrated in vacuo. The yield of the product (>99%) was determined from the 1H NMR spectrum of the crude product, with pyrazine as an internal standard. The product was isolated by preparative TLC (hexane–EtOAc, 4:1) as a white solid; yield: 76 mg (0.34 mmol, 98%); mp 126–132 °C. 1H NMR (400 MHz, CDCl3): δ = 7.36–7.28 (m, 4 H, Ar-H), 7.22–7.16 (m, 3 H, Ar-H), 7.07 (t, J = 7.6 Hz, 1 H, Ar-H), 6.91 (d, J = 7.6 Hz, 1 H, Ar-H), 4.62 (s, 1 H, CH), 3.26 (s, 3 H, NCH3). 13C NMR (100 MHz, CDCl3): δ = 176.0, 144.4, 136.6, 128.83, 128.79, 128.4 (two overlapping peaks), 127.5, 125.0, 122.7, 108.1, 52.0, 26.4.
  • 15 Mai C.-K, Sammons MF, Sammakia T. Org. Lett. 2010; 12: 2306